Article thumbnail

Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?

By Kenneth D. Westover, M. Brandon Westover, Eric P. Winer, Andrea L. Richardson, J. Dirk Iglehart and Rinaa S. Punglia


A negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristics may remain at unacceptably high risk of axillary disease even after a negative SLN biopsy result. A Bayesian nomogram was designed to combine the probability of axillary disease prior to nodal biopsy with customized test characteristics for an SLN biopsy and provides the probability of axillary disease despite a negative SLN biopsy. Users may individualize the sensitivity of an SLN biopsy based on factors known to modify the sensitivity of the procedure. This tool may be useful in identifying patients who should have expanded upfront exploration of the axilla or comprehensive axillary irradiation

Topics: Research Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). A .P a l ,E .P r o v e n z a n o
  2. (2003). A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy,”
  3. (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer,”
  4. (2010). A.E.Giuliano,L.McCall,P.Beitschetal.,“Locoregionalrecurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases,”
  5. (2005). An axilla scoring system to predict nonsentinel lymph node status in breast cancer patients with sentinel lymph node involvement,”
  6. (2009). Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer,”
  7. (2005). Correlation of magneticresonanceimagingandpathologicsizeofinfiltrating lobular carcinoma of the breast,”
  8. (2000). Diseases of the Breast,
  9. (1998). ea,A.D .Hill,A.M.El-Shirbin yetal.,“Sentinellymph node-biopsy in breast cancer: initial experience at memorial sloan-kettering cancer center,”
  10. (2005). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,”
  11. (1999). F´ ernandez-Cid,“Assessmentofbreastcancersize:sonographic and pathologic correlation,”
  12. (2006). Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase,”
  13. (2000). h e t t y ,W .J a c k ,R .J .P r e s c o t t ,C .T y l e r ,a n dA .R o d g e r , “Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial,”
  14. (1999). Importance of the level of axillary involvement in relation to traditionalInternational
  15. (1996). J.J.Albertini,G.H.Lyman,C.Coxetal.,“Lymphaticmapping and sentinel node biopsy in the patient with breast cancer,”
  16. (1955). J.W.Berg,“Thesignificanceofaxillarynodelevelsinthestudy of breast carcinoma,”
  17. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients,”
  18. (2003). Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer,”
  19. (2004). Randomized clinical trial comparing level II and level III axillary node dissectioninadditiontomastectomyforbreastcancer,”British
  20. (1996). Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes,”
  21. (2010). Sentinellymph-node resection compared with conventional axillarylymph-node dissection in clinically node-negative patients with breast cancer:
  22. (2007). Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from
  23. (1998). The Sentinel node in breast cancer. A multicenter validation study,”
  24. (2007). what are my chances of having a positive sentinel node? A validated nomogram for risk estimation,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.